{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:30:52Z","timestamp":1786991452888,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["NHCR-HC17C0020"],"award-info":[{"award-number":["NHCR-HC17C0020"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","award":["NHIS-2018-1-071"],"award-info":[{"award-number":["NHIS-2018-1-071"]}],"id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jamda.2019.08.017","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T08:27:11Z","timestamp":1571732831000},"page":"201-211.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study"],"prefix":"10.1016","volume":"21","author":[{"given":"Yeon-Hee","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Eun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kalisch Ellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2019.08.017_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/13651500903447810","article-title":"Usage of benzodiazepines: A review","volume":"14","author":"Donoghue","year":"2010","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.jamda.2019.08.017_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/gps.1950","article-title":"Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan","volume":"23","author":"Cheng","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.08.017_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13803395.2014.928268","article-title":"The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis","volume":"36","author":"Stranks","year":"2014","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"key":"10.1016\/j.jamda.2019.08.017_bib4","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABA(A) receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jamda.2019.08.017_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000336710","article-title":"CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: A longitudinal population-based study","volume":"2","author":"Puustinen","year":"2012","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"10.1016\/j.jamda.2019.08.017_bib6","series-title":"Medical Genetics Summaries","article-title":"Diazepam therapy and CYP2C19 genotype","author":"Dean","year":"2012"},{"key":"10.1016\/j.jamda.2019.08.017_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000028398","article-title":"The CYP2C19 enzyme polymorphism","volume":"61","author":"Wedlund","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.jamda.2019.08.017_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/clpt.1990.185","article-title":"Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: Interethnic differences in comparison with white subjects","volume":"48","author":"Zhang","year":"1990","journal-title":"Clin Pharmacol Therapeut"},{"key":"10.1016\/j.jamda.2019.08.017_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/phar.2170","article-title":"Association between development of dementia and use of benzodiazepines: A systematic review and meta-analysis","volume":"38","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jamda.2019.08.017_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-151006","article-title":"Regular benzodiazepine and Z-substance use and risk of dementia: An analysis of German claims data","volume":"54","author":"Gomm","year":"2016","journal-title":"JAD"},{"key":"10.1016\/j.jamda.2019.08.017_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/jgs.14756","article-title":"PTSD, psychotropic medication use, and the risk of dementia among US veterans: A retrospective cohort study","volume":"65","author":"Mawanda","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2019.08.017_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/JGP.0b013e3181e049ca","article-title":"Effect of benzodiazepine discontinuation on dementia risk","volume":"19","author":"Wu","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.08.017_bib13","first-page":"e6231","article-title":"Benzodiazepine use and risk of dementia: Prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.jamda.2019.08.017_bib14","first-page":"g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: Case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ (clinical research ed.)"},{"key":"10.1016\/j.jamda.2019.08.017_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimer Dement"},{"key":"10.1016\/j.jamda.2019.08.017_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer's disease or vascular dementia: A case-control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Safety"},{"key":"10.1016\/j.jamda.2019.08.017_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","article-title":"Benzodiazepine use and risk of developing Alzheimer's disease: A case-control study based on Swiss claims data","volume":"31","author":"Bietry","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jamda.2019.08.017_bib18","first-page":"i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: Prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ (clinical research ed)"},{"key":"10.1016\/j.jamda.2019.08.017_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: Evidence from the Caerphilly Prospective Study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J\u00a0Epidemiol Commun Health"},{"key":"10.1016\/j.jamda.2019.08.017_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3346\/jkms.2011.26.11.1461","article-title":"Overlapping medication associated with healthcare switching among Korean elderly diabetic patients","volume":"26","author":"Shin","year":"2011","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jamda.2019.08.017_bib21","first-page":"138","article-title":"Retrospective drugs utilization review study for chronic kidney disease using national health insurance database","volume":"53","author":"Kim","year":"2009","journal-title":"Yakhak Hoeji"},{"key":"10.1016\/j.jamda.2019.08.017_bib22","series-title":"Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database","author":"Park","year":"2017"},{"key":"10.1016\/j.jamda.2019.08.017_bib23","first-page":"143","article-title":"Prescription patterns of benzodiazepine for outpatients in a psychiatric department in Korea","volume":"11","author":"Lee","year":"2015","journal-title":"Anxiety Mood"},{"key":"10.1016\/j.jamda.2019.08.017_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.18773\/austprescr.2013.076","article-title":"Drug treatment for anxiety","volume":"36","author":"Lampe","year":"2013","journal-title":"Aust Prescriber"},{"key":"10.1016\/j.jamda.2019.08.017_bib25","first-page":"k1315","article-title":"Anticholinergic drugs and risk of dementia: Case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ (clinical research ed)"},{"key":"10.1016\/j.jamda.2019.08.017_bib26","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: Time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jamda.2019.08.017_bib27","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2014.55.6340","article-title":"Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials","volume":"32","author":"Campigotto","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jamda.2019.08.017_bib28","series-title":"Proceedings of the twenty-sixth Annual SAS\u00ae users group international conference","first-page":"214","article-title":"Reducing bias in a propensity score matched-pair sample using greedy matching techniques 2001","author":"Parsons","year":"2001"},{"key":"10.1016\/j.jamda.2019.08.017_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4065\/81.2.223","article-title":"Dementia and cerebrovascular disease","volume":"81","author":"Knopman","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jamda.2019.08.017_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","article-title":"Long-term benzodiazepine use and cognitive decline in the elderly: The Epidemiology of Vascular Aging Study","volume":"22","author":"Paterniti","year":"2002","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2019.08.017_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ageing\/afn277","article-title":"The risk of cognitive impairment in older community-dwelling women after benzodiazepine use","volume":"38","author":"Lagnaoui","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2019.08.017_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: Nested case-control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.08.017_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","article-title":"Benzodiazepine use and risk of dementia: A nested case-control study","volume":"55","author":"Lagnaoui","year":"2002","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jamda.2019.08.017_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0033291704003897","article-title":"Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies","volume":"35","author":"Verdoux","year":"2005","journal-title":"Psychol Med"},{"key":"10.1016\/j.jamda.2019.08.017_bib35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/aje\/kwz073","article-title":"History of nenzodiazepine prescriptions and risk of dementia: Possible bias due to prevalent users and covariate measurement timing in a nested case-control study","volume":"188","author":"Richardson","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2019.08.017_bib36","first-page":"553","article-title":"Korean medication algorithm project for generalized anxiety disorder 2009 (II): Medication algorithm and long-term medication treatment strategy","volume":"49","author":"Lee","year":"2010","journal-title":"J\u00a0Korean Neuropsychiatr Assoc"},{"key":"10.1016\/j.jamda.2019.08.017_bib37","first-page":"48","article-title":"Coexisting depression and anxiety: Special diagnostic and treatment issues","volume":"52","author":"Lydiard","year":"1991","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2019.08.017_bib38","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/jgs.15508","article-title":"Cumulative antidepressant use and risk of dementia in a prospective cohort study","volume":"66","author":"Heath","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2019.08.017_bib39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jamda.2019.08.017_bib40","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: Dangers, management, and alternative therapies","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jamda.2019.08.017_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5160","article-title":"Potentially inappropriate prescribing in people with dementia: An Australian population-based study","author":"Eshetie","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.08.017_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","article-title":"Immeasurable time bias in observational studies of drug effects on mortality","volume":"168","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2019.08.017_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YCO.0000000000000050","article-title":"Neuropsychiatric symptoms in the prodromal stages of dementia","volume":"27","author":"Stella","year":"2014","journal-title":"Curr Opin Psychiatry"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019306334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019306334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:21:06Z","timestamp":1761506466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861019306334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1525861019306334"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2019.08.017","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2019.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}